XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2018 $ 25 $ 4,267 $ (9,038) $ 64,476 $ (1,444) $ 58,286      
Balance (Accounting Standards Update 2016-02 [Member]) at Dec. 31, 2018             $ (362) $ 0 $ (362)
Balance (in shares) at Dec. 31, 2018           9,060,561      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense 0 186 0 0 0 $ 186      
Issuance of restricted stock $ 0 0 0 0 0 0      
Issuance of restricted stock (in shares) 1,408                
Purchase of treasury stock $ 0 0 $ (714) 0 0 (714)      
Purchase of treasury stock (in shares)     (127,945)            
Net income (loss) 0 0 $ 0 1,520 0 1,520 [1]      
Foreign currency translation adjustments, net of tax 0 0 0 0 314 314 [1]      
Balance at Mar. 31, 2019 [1] 25 4,453 (9,752) 65,634 (1,130) $ 59,230      
Balance (in shares) at Mar. 31, 2019 [1]           8,934,024      
Balance at Dec. 31, 2019 25 5,037 (9,773) 62,211 (1,081) $ 56,419      
Balance (in shares) at Dec. 31, 2019           9,022,187      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense 0 228 0 0 0 $ 228      
Issuance of restricted stock $ 0 0 0 0 0 0      
Issuance of restricted stock (in shares) 20,804                
Net income (loss) $ 0 0 0 (1,738) 0 (1,738) [2]      
Foreign currency translation adjustments, net of tax 0 0 0 0 (346) (346)      
Balance at Mar. 31, 2020 $ 25 $ 5,265 $ (9,773) $ 60,473 $ (1,427) $ 54,563      
Balance (in shares) at Mar. 31, 2020           9,042,991      
[1] As described in Note 2 to these Consolidated Financial Statements, we have restated the consolidated financial statements for the three months ended March 31, 2019
[2] For the three months ended March 31, 2020, there were 492 shares excluded from the diluted EPS calculation because the impact of their assumed vesting would be anti-dilutive due to a net loss in that period.